76 related articles for article (PubMed ID: 17681240)
1. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
[TBL] [Abstract][Full Text] [Related]
2. Phase III Trial: Adjuvant Pelvic Radiation Therapy Versus Vaginal Brachytherapy Plus Paclitaxel/Carboplatin in High-Intermediate and High-Risk Early Stage Endometrial Cancer.
Randall ME; Filiaci V; McMeekin DS; von Gruenigen V; Huang H; Yashar CM; Mannel RS; Kim JW; Salani R; DiSilvestro PA; Burke JJ; Rutherford T; Spirtos NM; Terada K; Anderson PR; Brewster WR; Small W; Aghajanian CA; Miller DS
J Clin Oncol; 2019 Jul; 37(21):1810-1818. PubMed ID: 30995174
[TBL] [Abstract][Full Text] [Related]
3. Partial-Length Treatment With Brachytherapy in Patients With Endometrial Cancer With High-Risk Features Is as Effective as Full-Length Vaginal Brachytherapy but With Reduced Toxicity.
Wernicke AG; Parashar B; Samuel E; Sabbas A; Gupta D; Caputo T
Pract Radiat Oncol; 2023; 13(5):e416-e422. PubMed ID: 37295725
[TBL] [Abstract][Full Text] [Related]
4. Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China.
Wang W; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Hu K; Zhang F; Hou X; Wei L; Zou L
BMC Womens Health; 2023 Aug; 23(1):417. PubMed ID: 37553639
[TBL] [Abstract][Full Text] [Related]
5. Image-guided high-dose-rate brachytherapy as the method of choice in medically inoperable early-stage endometrial cancer patients.
Rydzinski M; Bijok M; Michalski W; Kowalczyk A; Gruszczynska E; Zolciak-Siwinska A
Gynecol Oncol; 2024 Jan; 180():6-13. PubMed ID: 38035868
[TBL] [Abstract][Full Text] [Related]
6. High dose rate
Abtahi M; Gholami S; Jassim HH
Biomed Phys Eng Express; 2021 Aug; 7(5):. PubMed ID: 34375964
[No Abstract] [Full Text] [Related]
7. Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database.
Vanbraband J; Van Damme N; Silversmit G; De Geyndt A; Bouche G; Jacomen G; de Jonge E; Goffin F; Denys H; Amant F
Gynecol Oncol; 2024 Jan; 180():70-78. PubMed ID: 38086166
[TBL] [Abstract][Full Text] [Related]
8. Impact of Treatment Modality on Quality of Life Among Uterine Cancer Survivors.
Yoder AK; Lakomy DS; Wu J; Andring LM; Fellman B; Colbert LE; Jhingran A; Klopp AH; Soliman P; Peterson SK; Lin LL
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e215-e226. PubMed ID: 36494250
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate brachytherapy at 3 Gy per fraction for lip carcinoma: Treatment outcomes and toxicity at 5-years.
Tuček L; Sirák I; Hodek M; Kašaová L; Grepl J; Paluska P; Pohanková D; Hruška L; Vošmik M; Petera J
Brachytherapy; 2023; 22(4):496-502. PubMed ID: 37015847
[TBL] [Abstract][Full Text] [Related]
10. Malignant Bowel Obstruction Due to Intraluminal Metastasis of Endometrial Adenocarcinoma Located in the Sigmoid Colon After Nine Years of Follow-Up.
Matías-García B; Mendoza-Moreno F; Díez-Alonso M; D'Angelo C; Gutiérrez-Calvo A
Cureus; 2023 Oct; 15(10):e47937. PubMed ID: 38034275
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Incidence Rate of an Accelerated Short Course High Dose Rate Intravaginal Brachytherapy Complications in Patients with Endometrial Cancer.
Amouzegar Hashemi F; Vesgari Kiasari Z; Kalaghchi B; Aghili M; Gholami S; Mansouri S; Moalej S; Maddah Safaei A
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2039-2043. PubMed ID: 31350963
[TBL] [Abstract][Full Text] [Related]
12. A novel low dose fractionation regimen for adjuvant vaginal brachytherapy in early stage endometrioid endometrial cancer.
Townamchai K; Lee L; Viswanathan AN
Gynecol Oncol; 2012 Nov; 127(2):351-5. PubMed ID: 22850411
[TBL] [Abstract][Full Text] [Related]
13. Consensus on treatment of endometrium carcinoma with brachytherapy.
Guinot JL; Pérez-Calatayud J; Azcoaga JM; Herruzo I; Bodineau C; Rovirosa A; Crispín V; Galán P; González-Patiño E; Pérez-Regadera J; Polo A;
Clin Transl Oncol; 2012 Apr; 14(4):263-70. PubMed ID: 22484633
[TBL] [Abstract][Full Text] [Related]
14. Intravaginal 1-week high-dose-rate brachytherapy alone for Stages I-II endometrial cancer.
Martínez-Monge R; Nagore G; Cambeiro M; Garrán C; Villafranca E; Jurado M
Brachytherapy; 2007; 6(3):195-200. PubMed ID: 17681240
[TBL] [Abstract][Full Text] [Related]
15. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
Alektiar KM; Venkatraman E; Chi DS; Barakat RR
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of 1-week intravaginal high-dose-rate brachytherapy alone for endometrial cancer.
Gaztañaga M; Cambeiro M; Villafranca E; Vila M; Jurado M; Moreno M; Martínez-Monge R
Brachytherapy; 2012; 11(2):119-24. PubMed ID: 21684815
[TBL] [Abstract][Full Text] [Related]
17. Pathologic stage I-II endometrial carcinoma in the elderly: radiotherapy indications and outcome.
Citron JR; Sutton H; Yamada SD; Mehta N; Mundt AJ
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1432-8. PubMed ID: 15275729
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure in endometrial carcinoma stage IB grade 3 and IC patients treated with postoperative vaginal vault brachytherapy.
Chadha M; Nanavati PJ; Liu P; Fanning J; Jacobs A
Gynecol Oncol; 1999 Oct; 75(1):103-7. PubMed ID: 10502434
[TBL] [Abstract][Full Text] [Related]
19. Vaginal brachytherapy alone is sufficient adjuvant treatment of surgical stage I endometrial cancer.
Solhjem MC; Petersen IA; Haddock MG
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1379-84. PubMed ID: 16029796
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
